The BET-bromodomain inhibitor JQ1 mitigates vemurafenib drug resistance in melanoma | |
Zhao, Bei; Cheng, Xiankui; Zhou, Xiyuan | |
刊名 | MELANOMA RESEARCH
![]() |
2018 | |
卷号 | 28期号:6页码:521-526 |
关键词 | BET inhibitor BRAF inhibitor cancer drug resistance melanoma |
DOI | 10.1097/CMR.0000000000000497 |
URL标识 | 查看原文 |
公开日期 | [db:dc_date_available] |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4583765 |
专题 | 山东大学 |
作者单位 | Sichuan Acad Med Sci, Inst Dermatol & Venereol, 32 Western 2nd Sect,1st Circle Rd, Chengdu 610072, Sichuan, Peoples R China. |
推荐引用方式 GB/T 7714 | Zhao, Bei,Cheng, Xiankui,Zhou, Xiyuan. The BET-bromodomain inhibitor JQ1 mitigates vemurafenib drug resistance in melanoma[J]. MELANOMA RESEARCH,2018,28(6):521-526. |
APA | Zhao, Bei,Cheng, Xiankui,&Zhou, Xiyuan.(2018).The BET-bromodomain inhibitor JQ1 mitigates vemurafenib drug resistance in melanoma.MELANOMA RESEARCH,28(6),521-526. |
MLA | Zhao, Bei,et al."The BET-bromodomain inhibitor JQ1 mitigates vemurafenib drug resistance in melanoma".MELANOMA RESEARCH 28.6(2018):521-526. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论